Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

The C allele of JAK2 rs4495487 is an additional candidate locus that contributes to myeloproliferative neoplasm predisposition in the Japanese population

  • Junko H Ohyashiki1Email author,
  • Masayuki Yoneta2,
  • Hisashi Hisatomi2,
  • Tamiko Iwabuchi3,
  • Tomohiro Umezu4 and
  • Kazuma Ohyashiki3, 4
BMC Medical Genetics201213:6

DOI: 10.1186/1471-2350-13-6

Received: 18 August 2011

Accepted: 17 January 2012

Published: 17 January 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
18 Aug 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
19 Aug 2011 Author responded Author comments - Junko Ohyashiki
Resubmission - Version 3
19 Aug 2011 Submitted Manuscript version 3
30 Oct 2011 Reviewed Reviewer Report - Andrea Patriarca
27 Dec 2011 Author responded Author comments - Junko Ohyashiki
Resubmission - Version 4
27 Dec 2011 Submitted Manuscript version 4
29 Dec 2011 Reviewed Reviewer Report - Andrea Patriarca
11 Jan 2012 Author responded Author comments - Junko Ohyashiki
Resubmission - Version 5
11 Jan 2012 Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
16 Jan 2012 Author responded Author comments - Junko Ohyashiki
Resubmission - Version 7
16 Jan 2012 Submitted Manuscript version 7
Publishing
17 Jan 2012 Editorially accepted
17 Jan 2012 Article published 10.1186/1471-2350-13-6

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Molecular Oncology, Institute of Medical Science, Tokyo Medical University
(2)
Department of Materials and Life Science, Seikei University
(3)
First Department of Internal Medicine, Tokyo Medical University
(4)
Department of Molecular Science, Tokyo Medical University

Advertisement